Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-05-24
2011-05-24
Sullivan, Daniel M (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S510000
Reexamination Certificate
active
07947738
ABSTRACT:
It is intended to provide a bicyclic γ-amino acid derivative having excellent activity as an α2δ ligand. The present invention provides a compound represented by the general formula (I):wherein R1, R2, R2′, R4, R5, R6, R7, R8, and R8′are a hydrogen atom or the like; and R3is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like.
REFERENCES:
patent: 2003/0078300 (2003-04-01), Blakemore et al.
patent: 2004/0116525 (2004-06-01), Derrick
patent: 2010/0104575 (2010-04-01), Sooknanan et al.
patent: WO-99/21824 (1999-05-01), None
patent: WO-01/28978 (2001-04-01), None
patent: WO-02/085839 (2002-10-01), None
patent: WO-2004/006836 (2004-01-01), None
Bryans, , “Identification of Novel Ligands for the Gabapentin Binding Site on the α2δ Subunit of a Calcium Channel and Their Evaluation as Anticonvulsant Agents”,J. Med. Chem.(41) 1998, 1838-1845.
Frampton, James E. et al., “Pregabalin: In the Treatment of Painful Diabetic Peripheral Neuropathy”,Drugs,vol. 64, No. 24 2004, 2813-2820.
Gee, Nicolas S. et al., “The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel”,Journal of Biological Chemistry,vol. 271, No. 10 Mar. 8, 1996, 5768-5776.
Mann, Andre et al., “Synthesis and Biochemical Evaluation of Baclofen Analogs Locked in the Baclofen Solid-State Conformation”,Journal of Medicinal Chemistry, vol. 34, No. 4 1991, 1307-1313.
Nicholson, B. , “Gabapentin use in neuropathic pain syndromes”,Acta Neurol Scand, vol. 101 2000, 359-371.
Cott, Jerry, “Pharmacology Reviews,”Pharmacology/Toxicology Review and Evaluation,Food and Drug Administration, Center for Drug Evaluation and Research, NDA No. 21-446, May 24, 2004, pp. 1-136.
Arakawa Naohisa
Domon Yuki
Kawamura Asuka
Shimada Kousei
Daiichi Sankyo Company, Ltd.
Dorsey & Whitney LLP
Sawyer Jennifer C
Sullivan Daniel M
LandOfFree
Bicyclic γ-amino acid derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic γ-amino acid derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic γ-amino acid derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2655885